Latest news with #Conshohocken
Yahoo
08-07-2025
- Business
- Yahoo
Here's What to Expect From Cencora's Next Earnings Report
Valued at a market cap of $57.4 billion, Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a global healthcare solutions provider. The company specializes in pharmaceutical sourcing and distribution, providing a comprehensive range of services to healthcare providers and biopharmaceutical manufacturers throughout the U.S. and internationally. Cencora is slated to announce its fiscal Q3 2025 earnings results on Wednesday, Aug. 06. Ahead of the event, analysts forecast the company to report an adjusted EPS of $3.78, up 13.2% from $3.34 in the year-ago quarter. COR has surpassed Wall Street's bottom-line estimates in the past four quarterly reports. This Analyst Just Raised His Broadcom Stock Price Target by 70%. Should You Buy AVGO Now? Why Alibaba Stock Looks Like a Screaming Buy After Falling 27% From Its 2025 Highs 'Superintelligence' Takes Meta Platforms to Record Highs. Should You Buy META Stock Here? Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. For fiscal 2025, analysts project the prescription drug distributor to report adjusted EPS of $15.81, up 14.9% from $13.76 in fiscal 2024. Shares of Cencora have surged 35.9% over the past 52 weeks, outperforming both the S&P 500 Index's ($SPX) 11.9% rise and the Health Care Select Sector SPDR Fund's (XLV) nearly 7% decline over the same period. Shares of Cencora rose 4.7% on May 7 after the company raised its annual adjusted EPS forecast to a range of $15.70 to $15.95, surpassing analysts' average expectations. The upward revision was driven by strong demand for high-cost specialty medicines and GLP-1 weight-loss drugs, which significantly boosted revenue. Additionally, the company posted Q2 2025 adjusted profit of $4.42 per share and revenue of $75.5 billion, both exceeding analyst estimates. Analysts' consensus rating on Cencora stock is bullish, with an overall 'Strong Buy' rating. Among 15 analysts covering the stock, 12 recommend a "Strong Buy' and three give a "Hold" rating. This configuration is slightly more bullish than three months ago, with 11 analysts suggesting a "Strong Buy." As of writing, the stock is trading below the average analyst price target of $329. On the date of publication, Sohini Mondal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Associated Press
03-07-2025
- Business
- Associated Press
Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Jul 3, 2025-- Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Third Quarter of Fiscal 2025 on Wednesday, August 6, 2025, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on August 6, 2025. Participating in the conference call will be: Robert P. Mauch, President & Chief Executive Officer James F. Cleary, Executive Vice President & Chief Financial Officer The live call will be webcast via the Company's website at Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call. To access the call via telephone from within the United States and Canada, dial +1 (833) 470-1428. From outside the United States and Canada, dial +1 (404) 975-4839. The access code for the call will be 015103. Replays of the call will be made available via telephone and webcast. A replay of the webcast will be posted on approximately one hour after the completion of the call and will remain available for one year. The telephonic replay will also be available approximately one hour after the completion of the call and will remain available for 7 days. To access the telephonic replay from within the United States and Canada, dial +1 (866) 813-9403. From outside the United States, dial +1 (929) 458-6194. The access code for the replay is 676245. Please check the website for updates regarding the timing of the live webcasts and for replay information. About Cencora Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. Cencora partners with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on Cencora for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Cencora's 51,000+ worldwide team members contribute to positive health outcomes through the power of Cencora's purpose: Cencora is united in its responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #18 on the Global Fortune 500 with more than $290 billion in annual revenue. Learn more at View source version on CONTACT: Bennett S. Murphy Senior Vice President, Head of Investor Relations and Treasury [email protected] KEYWORD: UNITED STATES NORTH AMERICA PENNSYLVANIA INDUSTRY KEYWORD: HEALTH OTHER HEALTH OTHER SCIENCE RESEARCH SCIENCE PHARMACEUTICAL VETERINARY SOURCE: Cencora Copyright Business Wire 2025. PUB: 07/03/2025 07:30 AM/DISC: 07/03/2025 07:31 AM
Globe and Mail
27-06-2025
- Entertainment
- Globe and Mail
Julia Miralles Releases Powerful New Single: ‘Just One Minute (What a Waste)'
Rising indie-pop artist Julia Miralles has released her bold and emotionally-charged new single, 'Just One Minute (What a Waste).' The track, available now for streaming here, showcases Julia's signature lyrical vulnerability and soaring vocals, wrapped in a richly dynamic production. The single was produced by John Faye, acclaimed frontman of The Caulfields, and mixed and mastered at the legendary Studio 4 in Conshohocken, PA. 'Just One Minute (What a Waste)' explores the weight of emotional miscommunication and the brief but painful moments that can define — and undo — a connection. Julia's poignant lyrics and raw delivery cut to the core, capturing the complexity of heartbreak in just under four minutes. 'I wanted to capture how it feels when a single moment undoes everything — and how powerless that can make you feel,' says Miralles. 'Working with John and recording at Studio 4 made it possible to bring that vision to life.' The single is Julia's most polished and personal release to date and marks the beginning of a new chapter in her evolving sound — blending alt-pop energy with intimate storytelling. LINK: Official Release Date: June 27, 2025 For interviews, press inquiries, or promo materials, please contact: juliamirallesofficial@ Follow Julia Miralles on Instagram, TikTok, and Spotify for updates and upcoming tour dates. Media Contact Company Name: Julia Miralles Music Contact Person: Julia Miralles Email: Send Email Country: United States Website:
Yahoo
29-05-2025
- Business
- Yahoo
Hamilton Lane: Fiscal Q4 Earnings Snapshot
CONSHOHOCKEN, Pa. (AP) — CONSHOHOCKEN, Pa. (AP) — Hamilton Lane Inc. (HLNE) on Thursday reported fiscal fourth-quarter profit of $50.5 million. The Conshohocken, Pennsylvania-based company said it had profit of $1.23 per share. Earnings, adjusted for one-time items, came to $1.21 per share. The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1.20 per share. The private-market investment firm posted revenue of $198 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $173.6 million. For the year, the company reported profit of $217.4 million, or $5.41 per share. Revenue was reported as $713 million. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on HLNE at
Yahoo
29-05-2025
- Business
- Yahoo
HAMILTON LANE INCORPORATED REPORTS STRONG FOURTH FISCAL QUARTER AND FISCAL YEAR 2025 RESULTS, WITH MANAGEMENT AND ADVISORY FEES GROWING BY 14% AND ASSETS UNDER MANAGEMENT GROWING BY 11% YEAR-OVER-YEAR
CONSHOHOCKEN, Pa., May 29, 2025 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) today reported its results for the fourth fiscal quarter and full fiscal year ended March 31, 2025. FISCAL YEAR 2025 HIGHLIGHTS Assets under management – Total assets under management of $138 billion grew 11% year-over-year. Fee-earning assets under management increased 10% to $72 billion over the same period. Revenue – Management and advisory fees increased 14% to $513.9 million for fiscal 2025. Carried Interest – Unrealized carried interest balance of $1.3 billion was up 3% year-over-year. Earnings per share – GAAP EPS of $5.41 on $217.4 million of GAAP net income for fiscal 2025. Dividend – Declared a quarterly dividend of $0.54 per share of Class A common stock to record holders at the close of business on June 20, 2025 that will be paid on July 7, 2025. The target full-year dividend of $2.16 represents a 10% increase from the prior fiscal year dividend. Hamilton Lane issued a full detailed presentation of its fourth quarter and full fiscal year 2025 results, which can be accessed on the Company's Shareholders website at Conference CallHamilton Lane will discuss fourth quarter and full fiscal year 2025 results in a webcast and conference call today, Thursday, May 29, 2025, at 11:00 a.m. Eastern Time. For access to the live event via the webcast, visit Hamilton Lane's Shareholders website ( at least 15 minutes prior to the start of the call. This feature will be in listen-only mode. A replay of the webcast will be available approximately two hours after the live broadcast for a period of one year and can be accessed in the same manner as the live webcast at the Shareholders page of Hamilton Lane's website. About Hamilton LaneHamilton Lane (Nasdaq: HLNE) is one of the largest private markets investment firms globally, providing innovative solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 760 professionals operating in offices throughout North America, Europe, Asia Pacific and the Middle East. Hamilton Lane has $957.8 billion in assets under management and supervision, composed of $138.3 billion in discretionary assets and $819.5 billion in non-discretionary assets, as of March 31, 2025. Hamilton Lane specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors and geographies. For more information, please visit or follow Hamilton Lane on LinkedIn: Forward-Looking StatementsSome of the statements in this release may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Words such as "will," "expect," "believe," "estimate," "continue," "anticipate," "intend," "plan" and similar expressions are intended to identify these forward-looking statements. Forward-looking statements discuss management's current expectations and projections relating to our financial position, results of operations, plans, objectives, future performance and business. All forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause actual results to be materially different, including risks relating to: our ability to manage growth, fund performance, competition in our industry, changes in our regulatory environment and tax status; difficult or volatile market conditions; our ability to access suitable investment opportunities for our clients; our ability to maintain our fee structure; our ability to attract and retain key employees; our ability to manage our obligations under our debt agreements; defaults by clients and third-party investors on their obligations to fund commitments; our exposure and that of our clients and investors to the credit risks of financial institutions at which we and they hold accounts; our ability to comply with investment guidelines set by our clients; our ability to successfully integrate acquired businesses with ours; our ability to manage risks associated with introducing new types of investment structures, products or services or entering into strategic partnerships; our ability to manage redemption or repurchase rights in certain of our funds; our ability to manage, identify and anticipate risks we face; our ability to manage the effects of events outside of our control; and our ability to receive distributions from Hamilton Lane Advisors, L.L.C. to fund our payment of dividends, taxes and other expenses. The foregoing list of factors is not exhaustive. For more information regarding these risks and uncertainties as well as additional risks that we face, you should refer to the "Risk Factors" detailed in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2024 and in our subsequent reports filed from time to time with the Securities and Exchange Commission, including our upcoming Annual Report on Form 10-K for fiscal 2025. The forward-looking statements included in this release are made only as of the date hereof. We undertake no obligation to update or revise any forward-looking statement as a result of new information or future events, except as otherwise required by law. SOURCE Hamilton Lane Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
